Immunogenicity, efficacy, and safety of SARS-CoV-2 vaccine dose fractionation: a systematic review and meta-analysis

BACKGROUND: Dose fractionation of a coronavirus disease 2019 (COVID-19) vaccine could effectively accelerate global vaccine coverage, while supporting evidence of efficacy, immunogenicity, and safety are unavailable, especially with emerging variants. METHODS: We systematically reviewed clinical tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Bingyi, Huang, Xiaotong, Gao, Huizhi, Leung, Nancy H., Tsang, Tim K., Cowling, Benjamin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595080/
https://www.ncbi.nlm.nih.gov/pubmed/36284331
http://dx.doi.org/10.1186/s12916-022-02600-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595080/
https://www.ncbi.nlm.nih.gov/pubmed/36284331
http://dx.doi.org/10.1186/s12916-022-02600-0

Ejemplares similares